Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Infection
100%
In Vitro
100%
Angiotensin Converting Enzyme 2
100%
Peptidase
100%
Coronavirus
100%
Ubiquitin
100%
Antiviral Activity
22%
Disease
11%
Pneumonia
11%
COVID-19
11%
Antivirus Agent
11%
Pharmacokinetics
11%
Pandemic
11%
Transgenic Mouse
11%
Deubiquitinase
11%
Keyphrases
COVID-19
100%
Coronavirus
100%
Preventing Infection
100%
Angiotensin-converting Enzyme 2 (ACE2)
100%
Ubiquitin-specific Peptidase
100%
ML364
33%
Antiviral Activity
22%
Viral Load
11%
Small Molecule Inhibitors
11%
Therapeutic Potential
11%
Future Pandemics
11%
Transgenic Mouse Model
11%
COVID-19 Pandemic
11%
Pharmacokinetic Effects
11%
Antiviral Target
11%
Targeted Inhibition
11%
Protein Abundance
11%
Effective Approach
11%
In Vivo Performance
11%
Control Disease
11%
Lung Inflammation
11%
Host-targeted Antiviral
11%
Deubiquitinase
11%
Oral Therapeutics
11%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
SARS Coronavirus
100%
Angiotensin Converting Enzyme 2
100%
Peptidase
100%
Ubiquitin
100%
Antiviral Activity
22%
Disease
11%
Pneumonia
11%
Mouse Model
11%
Antivirus Agent
11%
Transgenic Mouse
11%
Pandemic
11%
Lead Compound
11%
Deubiquitinase
11%
Pharmacokinetics
11%